Skip to main content
Damartex logo

Damartex — Investor Relations & Filings

Ticker · ALDAR ISIN · FR0000185423 LEI · 9695003JO5WBTYFJQW28 PA Wholesale and retail trade
Open in API
Filings indexed 413 across all filing types
Latest filing 2022-03-09 Interim / Quarterly Rep…
Country FR France
Listing PA ALDAR

About Damartex

https://damartex.com/en/

Damartex is a European retail group specializing in the 'silver economy,' catering to consumers aged 55 and over. The company operates a portfolio of specialized brands across three main divisions: Fashion, Home & Lifestyle, and Healthcare. The Fashion division offers clothing and accessories adapted for seniors through brands like Damart and Afibel. The Home & Lifestyle division provides products for home living and decoration. The Healthcare division delivers home health services, including specialized care such as infusion and nutrition support. The group's mission is to support the well-being of seniors by providing innovative products and services tailored to their specific needs and expectations.

Recent filings

Filing Released Lang Actions
DAMARTEX / Résultats du premier semestre de l’exercice 2021/2022
Interim / Quarterly Report Classification · 1% confidence The document provides a summary of financial results for the first half of the 2021/2022 fiscal year, including a consolidated data table (revenue, EBITDA, net income), analysis of business segments (Fashion, Home & Lifestyle, Healthcare), and financial position. It is a comprehensive report of interim financial performance rather than just a brief announcement or a press release, as it contains substantive financial data and management commentary. Therefore, it is classified as an Interim/Quarterly Report (IR). H1 2021
2022-03-09 French
DAMARTEX / Acquisition de la société JP Consult
Regulatory Filings Classification · 1% confidence The document announces the acquisition of a company (JP Consult) by Santéol holding, which is part of the Damartex Group. This is a corporate action related to mergers, acquisitions, or significant business restructuring. Based on the provided definitions, the most fitting category for an announcement regarding a merger proposal or takeover bid is 'M&A Activity' (Code: TAR). Although it is a press release format, the core subject is M&A, which is more specific than the general 'Regulatory Filings' (RNS). The document length is short (2873 chars), but it contains the full substance of the announcement, not just a notice that a report is attached, thus ruling out RPA.
2022-03-08 French
DAMARTEX / Droits de vote bruts et réels 28 février 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a monthly update (as of February 28, 2022) on the total number of shares and voting rights. This type of mandatory periodic disclosure regarding the capital structure and voting rights is best classified as a general Regulatory Filing (RNS) or potentially a specific capital/share update. Given the options, it is a mandatory regulatory disclosure about the share capital structure, which aligns closely with general regulatory announcements or share-related updates. Since there isn't a specific code for 'Monthly Voting Rights Disclosure', and it is a formal regulatory filing providing key share data, RNS (Regulatory Filings) is the most appropriate fallback, although it contains elements related to 'SHA' (Share Issue/Capital Change). However, RNS covers general regulatory announcements that don't fit elsewhere. Given the structure and content, it is a formal regulatory disclosure. Revisiting the definitions: It is not a DVA (Declaration of Voting Results), as that is for results *from* a meeting. It is a periodic disclosure of the capital base. It is a formal regulatory filing. Considering the options, 'RNS' (Regulatory Filings) is the best fit for a mandatory, periodic regulatory disclosure that doesn't match a more specific category like DIV, SHA, or DVA.
2022-03-07 French
DAMARTEX / Acquisition de la société PERF R
M&A Activity Classification · 1% confidence The document announces the acquisition of a company (Perf R) by Santéol Ile-de-France, which is part of the Damartex group. This is a corporate action related to mergers, acquisitions, or significant structural changes. Based on the provided definitions, the most fitting category for an announcement regarding a merger proposal or takeover bid is 'M&A Activity' (Code: TAR). Although it is an acquisition, it is not a general regulatory filing (RNS) or a financing update (CAP). It is a specific announcement about a transaction, aligning best with TAR.
2022-02-28 French
DAMARTEX / Droits de vote bruts et réels 31 janvier 2022
Share Issue/Capital Change Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relative to the Total Number of Voting Rights and Shares Comprising the Share Capital). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a monthly update (as of January 31, 2022) on the total number of shares and voting rights. This type of mandatory periodic disclosure regarding the capital structure and voting rights does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory disclosure concerning share capital and voting rights, which is best categorized under the general 'Regulatory Filings' (RNS) as a fallback, or potentially 'Share Issue/Capital Change' (SHA) if the focus was purely on changes, but RNS serves as the best fit for mandatory, non-standardized regulatory updates not covered elsewhere. Given the specific nature of reporting total voting rights monthly, RNS is the most appropriate general regulatory filing category.
2022-02-18 French
DAMARTEX / Xandres fait son entrée sur le marché allemand
Regulatory Filings Classification · 1% confidence The document announces the launch of the Xandres brand (part of the Damartex group) into the German market via a press conference on February 16, 2022. It details the brand, distribution channels, and partnership with celebrities. This is a corporate announcement regarding business expansion and market entry, not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It fits best under a general announcement category. Since it is a specific business update that doesn't fit the highly specialized categories (like M&A, Capital Change, or Director Dealing), it is classified as a Regulatory Filing (RNS) as the general fallback for corporate news releases that aren't explicitly defined elsewhere.
2022-02-17 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.